Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed360%
unknown120%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

Upright MRI for Prostate Cancer Screening

NCT03474913
completednot_applicable

Variations of Portal Flow During the Respiratory Cycle in Healthy Volunteers

NCT04782531
completednot_applicable

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

NCT02956473
completednot_applicable

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

NCT03188354
unknownnot_applicable

Identification of New Markers of Atrial Myopathy in Patients With Embolic Stroke of Undetermined Source (ESUS) From MRI 4D Data

NCT04717843

Clinical Trials (5)

Showing 5 of 5 trials
NCT03474913

Upright MRI for Prostate Cancer Screening

Recruiting
NCT04782531Not Applicable

Variations of Portal Flow During the Respiratory Cycle in Healthy Volunteers

Completed
NCT02956473Not Applicable

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Completed
NCT03188354Not Applicable

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Completed
NCT04717843Not Applicable

Identification of New Markers of Atrial Myopathy in Patients With Embolic Stroke of Undetermined Source (ESUS) From MRI 4D Data

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5